Institutional investors purchased a net $536.0 thousand shares of ICLR during the quarter ended December 2012 and now own 89.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
| Mutual fund holders | 49.31% |
| Other institutional | 40.39% |
| Individual stakeholders | -- |